期刊文献+

小儿肺咳颗粒对急性小儿支气管炎治疗的临床观察 被引量:10

Clinical Effects of Pediatric Lung Cough Particles on Acute Bronchitis in Children
下载PDF
导出
摘要 目的:研究小儿肺咳颗粒对急性小儿支气管炎的临床疗效。方法:选取2012年7月-2014年7月笔者所在医院接诊的280例急性支气管炎患儿,按照随机数字表法分为两组,观察组200例(小儿肺咳颗粒),对照组80例(头孢噻肟静滴),观测临床症状体征量化得分、临床症状以及不良反应。治疗一疗程,评定疗效。结果:治疗后,两组患儿治疗前后临床症状体征量化得分均减少,与治疗前比较差异均有统计学意义(P<0.05)。治疗后,观察组患儿临床症状体征量化得分明显少于对照组,两组比较差异有统计学意义(P<0.05)。观察组患儿治疗总有效率为92.50%,明显高于对照组的78.75%,两组比较差异有统计学意义(P<0.05)。观察组患者喘息症状消失更快,两组比较差异有统计学意义(P<0.05)。两组咳嗽和肺部湿啰音两项体征消失时间比较差异均无统计学意义(P>0.05)。结论:小儿肺咳颗粒治疗急性小儿支气管炎有显著效果,值得在临床上推广。 Objective:To study the clinical effects of Pediatric Lung Cough Particles on acute bronchitis in children.Method:280 patients with acute bronchitis from July 2012 to July 2014 in our hospital were studied.The patients were randomly divided into two groups, the observation group, 200 cases(Pediatric Lung Cough Particles), and the control group, 80 cases(cefotaxime by intravenous dripping).The clinical symptoms,clinical signs and symptoms score to quantify adverse reactions were observed. A course of treatment to determine efficacy.Result: The clinical signs and symptoms score of the two groups were all significantly reducing(P〈0.05).And the observation group compared with the control group was reducing more significantly(P〈0.05).The overall efficiency of observation group was higher(P〈0.05). The disappearing time of wheezing symptoms was less in observation group(P〈0.05). Conclusion: The clinical effects of Pediatric Lung Cough Particles on acute bronchitis in children is significant. And it should be promoted in clinical practice.
作者 王晴晴 过桥
出处 《中外医学研究》 2014年第33期28-30,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 小儿肺咳颗粒 急性小儿支气管炎 疗效 Pediatric Lung Cough Particles Acute bronchitis Clinical effects
  • 相关文献

参考文献7

二级参考文献45

  • 1殷勇,周纬,肖洁,俞宏真.痰热清注射液治疗儿童急性呼吸道感染的临床观察[J].中国中西医结合急救杂志,2005,12(1):37-39. 被引量:49
  • 2姜兴权,宋德彪,刘海波,胡家昌.痰热清注射液对机械通气患者肺保护作用的临床研究[J].中国中西医结合急救杂志,2006,13(2):80-82. 被引量:14
  • 3李丽贤,黄晓巍,张永和,周鸣,邓毅峰.抗感颗粒抗炎解热镇痛作用的实验研究[J].中国社区医师(医学专业),2006,8(17):18-19. 被引量:5
  • 4上海中医学院方药教研组.中药临床手册[M].上海:上海人民出版社,1997.111.
  • 5Abraham E,Arcaroli J,Carmody A,et al.Cutting edge;HMG-1 as a mediator of acute lung inflammation[J].JImmunol,2000,165 (6):2950.
  • 6Anderssion U,Wang H,Palmblad K,et al.High mobilitygroup 1 protein (HMG-1) stimulates proinflammatorycytokine synthesis in human monocytes[J].J Exp Med,2000,192(4):565.
  • 7Lin X,Yang H,Sakuragi T,et al.Alpha-chemokinereceptor blockade reduces high mobility group box 1protein-induced lung inflammation and injury andimproves survival in sepsis[J].Am J Physiol Lung CellMol Physiol,2005,289(4):L583.
  • 8Chen HZ.Practical Int Med.Beijing:Peoples Medical Publishing House,2006,12:1661.
  • 9Licberman D,Schlaeffer F,Boldur I,et al.Multiple pathogens in adult patients admitted with community-acquired pneumonia:a one year prospective study of 346 consecutive patients.Thorox,1996,51(2):179-184.
  • 10Antcla A,Gucrrero A,Meseguer M,et al.Community-acquired pneumonia:prospective study of 101 adult,immunocompetent patients for 1 year.Enferm Infect Microbiol Clin,1993,11(10):525-530.

共引文献47

同被引文献70

引证文献10

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部